- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00211835
Treatment of Post-TBI Depression
Treatment of Post-TBI Depression - A Randomized Clinical Trial
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Goals Demonstrate the efficacy of cognitive behavioral therapy (CBT), both immediately after treatment and in the long term, in alleviating post-TBI depression.
Examine the relationship between improved mood, participation, and life satisfaction.
Implement exploratory analyses of the relationships between person and injury characteristics and outcomes of treatment.
Maximize potential application to clinical practice by:
Implementing the treatment in a clinical context so that its utility is demonstrated in a setting that maximizes ecological validity, and Creating and disseminating a manual detailing CBT treatment. This study is a randomized clinical trial that compares two treatment conditions: CBT and supportive psychotherapy (SPT). CBT has been shown to be effective in diverse studies. In this study, CBT has been shaped to be used specifically with people with typical post-TBI cognitive challenges. All participants will be given an opportunity to immediately receive a randomly assigned psychotherapy intervention to potentially enhance coping. Both CBT and SPT will involve 16 sessions of individual treatment. The initial session will be 90 minutes, with remaining sessions 50 minutes. In both treatments, participants will be seen for three months, with sessions twice weekly for the first month and once a week subsequently. The research assistants who will administer pre- and postintervention evaluation instruments will be blind to each participant's randomly assigned treatment condition. Evaluation instruments will be administered at baseline and at three points of follow-up: one week, six months, and one year after treatment. A detailed manual describing treatment methods will be developed based on the intervention.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
New York
-
New York, New York, Forente stater, 10029-6574
- Icahn School of Medicine at Mount Sinai
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Being at least 18years old
- Having a TBI as a result of a blow to the head followed by a loss of consciousness or period of being dazed and confused or a period of post traumatic amnesia or clinical signs of altered neurological function; this information must be medically documented (e.g., emergency medical record, hospital record, neuroradiological report, or neurological exam or record of physician's visit within 24 hours of injury)
- Being at least 6 months post injury
- Being English-speaking
- Having residential telephone service
- Living within 1.5 hours of New York City
- Having at least a sixth-grade reading level
- Meeting DSM-IV criteria for a current depressive mood disorder
- Not being in psychotherapy and being willing to abstain from seeking psychotherapy during the course of participation
- Being willing to complete questionnaires and interviews about mood, thinking skills, community participation and life satisfaction
- Agreeing to participate, verified by completion of informed consent and HIPAA documents.
- Individuals who meet criteria and are currently using prescribed mood medications will be included in the study if dosage has been stable for sixty days.
Exclusion Criteria:
- Pre-existing neurological disorder, including brain injury from an etiology other than trauma
- History of mental retardation
- Lack of capacity to sign informed consent
- Taking antidepressant medications for less than six months
- Having any changes in antidepressant medications in the last six months
- History of current or past psychosis or mania
- Current substance abuse
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Treatment Arm 1
Individual psychotherapy focused on identifying and correcting maladaptive cognitions and behaviors with the goal of improving mood.
The intervention has adapted CBT specifically to address cognitive deficits associated with TBI, which compound the cognitive distortions typical of depression.
CBT therapists embed compensatory strategies within treatment sessions to address cognitive limitations of each participant.
|
Individual psychotherapy focused on identifying and correcting maladaptive cognitions and behaviors with the goal of improving mood.
The intervention has adapted CBT specifically to address cognitive deficits associated with TBI, which compound the cognitive distortions typical of depression.
CBT therapists embed compensatory strategies within treatment sessions to address cognitive limitations of each participant.
|
Eksperimentell: Treatment Arm 2
A client-centered individual psychotherapy treatment approach designed to address depressive disorders commonly experienced by individuals following a TBI.
In line with traditional supportive psychotherapy approaches, the objective of SPT is to improve the individual's ability to deal with problems of daily living more effectively through problem identification, praise, reassurance, encouragement, psychoeducation, advice, anticipatory guidance, and expanding awareness.
|
A client-centered individual psychotherapy treatment approach designed to address depressive disorders commonly experienced by individuals following a TBI.
In line with traditional supportive psychotherapy approaches, the objective of SPT is to improve the individual's ability to deal with problems of daily living more effectively through problem identification, praise, reassurance, encouragement, psychoeducation, advice, anticipatory guidance, and expanding awareness.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Remission of depression (DSM-IV diagnosis no longer met)
Tidsramme: baseline
|
baseline
|
Remission of depression (DSM-IV diagnosis no longer met)
Tidsramme: one week after treatment completion
|
one week after treatment completion
|
Remission of depression (DSM-IV diagnosis no longer met)
Tidsramme: six months after treatment completion
|
six months after treatment completion
|
Remission of depression (DSM-IV diagnosis no longer met)
Tidsramme: one year after treatment completion
|
one year after treatment completion
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Increased participation (Participation Objective, Participation Subjective)
Tidsramme: baseline
|
baseline
|
Improved quality of life (Life-3).
Tidsramme: baseline
|
baseline
|
Increased participation (Participation Objective, Participation Subjective)
Tidsramme: one week after treatment completion
|
one week after treatment completion
|
Increased participation (Participation Objective, Participation Subjective)
Tidsramme: six months after treatment completion
|
six months after treatment completion
|
Increased participation (Participation Objective, Participation Subjective)
Tidsramme: one year after treatment completion
|
one year after treatment completion
|
Improved quality of life (Life-3).
Tidsramme: one week after treatment completion
|
one week after treatment completion
|
Improved quality of life (Life-3).
Tidsramme: six months after treatment completion
|
six months after treatment completion
|
Improved quality of life (Life-3).
Tidsramme: one year after treatment completion
|
one year after treatment completion
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Wayne Gordon, Ph.D., Icahn School of Medicine at Mount Sinai
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- GCO 04-0782
- H133B040033
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Cognitive behavioral therapy
-
Medical University of South CarolinaNational Institute of Mental Health (NIMH)Påmelding etter invitasjonDepresjon | Depressive symptomerForente stater
-
Medical University of South CarolinaRekrutteringDepresjon | Kreft | Depressive symptomerForente stater
-
Nemours Children's ClinicFullførtDiabetes mellitus, type 2 | BarnefedmeForente stater
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health...FullførtDepresjon | Depressive symptomer | UngdomsadferdForente stater
-
Nemours Children's ClinicFullførtDiabetes mellitus, type 2 | BarnefedmeForente stater
-
Medical University of South CarolinaDrug Abuse Research Training ProgramFullført
-
Hacettepe UniversityPåmelding etter invitasjonMotorisk aktivitet | Eksekutiv dysfunksjon | Kognitiv orienteringTyrkia
-
Texas Tech UniversityHar ikke rekruttert ennåSorg | Psykisk helseproblem | Byrde, omsorgspersonForente stater
-
Imperial College LondonNHS England (NHSE/I) LondonFullført
-
Sidney Kimmel Cancer Center at Thomas Jefferson...FullførtBrystkarsinomForente stater